Literature DB >> 33122000

Neutrophil signaling during myocardial infarction wound repair.

Michael J Daseke1, Upendra Chalise2, Mediha Becirovic-Agic3, Jeffrey D Salomon4, Leah M Cook5, Adam J Case3, Merry L Lindsey6.   

Abstract

Neutrophils are key effector cells of the innate immune system, serving as a first line of defense in the response to injury and playing essential roles in the wound healing process. Following myocardial infarction (MI), neutrophils infiltrate into the infarct region to propagate inflammation and begin the initial phase of cardiac wound repair. Pro-inflammatory neutrophils release proteases to degrade extracellular matrix (ECM), a necessary step for the removal of necrotic myocytes as a prelude for scar formation. Neutrophils transition their phenotype over time to regulate MI inflammation resolution and stabilize scar formation. Neutrophils contribute to the evolution from inflammation to resolution and scar formation by serving anti-inflammatory and repair functions. As anti-inflammatory cells, neutrophils contribute ECM proteins during scar formation, in particular fibronectin, galectin-3, and vimentin. The diverse and polarizing functions that contribute to MI wound repair make this innate immune cell a viable target to improve MI outcomes. Thus, understanding the signaling involved in neutrophil physiology in the context of MI may help to identify novel therapeutic targets.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Inflammation; Leukocyte; Myocardial infarction; Neutrophil; Signaling; Wound repair

Mesh:

Substances:

Year:  2020        PMID: 33122000      PMCID: PMC7718402          DOI: 10.1016/j.cellsig.2020.109816

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  118 in total

1.  Subcellular localization and release of human neutrophil gelatinase, confirming the existence of separate gelatinase-containing granules.

Authors:  L Kjeldsen; O W Bjerrum; J Askaa; N Borregaard
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

2.  Inhibition of pro-inflammatory myeloid cell responses by short-term S100A9 blockade improves cardiac function after myocardial infarction.

Authors:  Goran Marinković; Helena Grauen Larsen; Troels Yndigegn; Istvan Adorjan Szabo; Razvan Gheorghita Mares; Lisa de Camp; Matthew Weiland; Lukas Tomas; Isabel Goncalves; Jan Nilsson; Stefan Jovinge; Alexandru Schiopu
Journal:  Eur Heart J       Date:  2019-08-21       Impact factor: 29.983

3.  Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction.

Authors:  Z Li; H Jiang; W Xie; Z Zhang; A V Smrcka; D Wu
Journal:  Science       Date:  2000-02-11       Impact factor: 47.728

4.  Integrin-induced PIP5K1C kinase polarization regulates neutrophil polarization, directionality, and in vivo infiltration.

Authors:  Wenwen Xu; Ping Wang; Björn Petri; Yong Zhang; Wenwen Tang; Le Sun; Holger Kress; Tom Mann; Yan Shi; Paul Kubes; Dianqing Wu
Journal:  Immunity       Date:  2010-09-24       Impact factor: 31.745

5.  Kinase pathways in chemoattractant-induced degranulation of neutrophils: the role of p38 mitogen-activated protein kinase activated by Src family kinases.

Authors:  A Mócsai; Z Jakus; T Vántus; G Berton; C A Lowell; E Ligeti
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

6.  Neutrophil elastase induces IL-8 synthesis by lung epithelial cells via the mitogen-activated protein kinase pathway.

Authors:  Hao-Cheng Chen; Horng-Chyuan Lin; Chien-Ying Liu; Chun-Hua Wang; Tritium Hwang; Tzu-Ting Huang; Chien-Huang Lin; Han-Pin Kuo
Journal:  J Biomed Sci       Date:  2004 Jan-Feb       Impact factor: 8.410

7.  Dynamics of Cardiac Neutrophil Diversity in Murine Myocardial Infarction.

Authors:  Ehsan Vafadarnejad; Giuseppe Rizzo; Laura Krampert; Panagiota Arampatzi; Anahi-Paula Arias-Loza; Yara Nazzal; Anna Rizakou; Tim Knochenhauer; Sourish Reddy Bandi; Vallery Audy Nugroho; Dirk J J Schulz; Melanie Roesch; Paul Alayrac; Jose Vilar; Jean-Sébastien Silvestre; Alma Zernecke; Antoine-Emmanuel Saliba; Clément Cochain
Journal:  Circ Res       Date:  2020-08-19       Impact factor: 17.367

Review 8.  Androgen receptor influences on body defense system via modulation of innate and adaptive immune systems: lessons from conditional AR knockout mice.

Authors:  Jiann-Jyh Lai; Kuo-Pao Lai; Weiping Zeng; Kuang-Hsiang Chuang; Saleh Altuwaijri; Chawnshang Chang
Journal:  Am J Pathol       Date:  2012-09-04       Impact factor: 4.307

9.  Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization.

Authors:  G J Lieschke; D Grail; G Hodgson; D Metcalf; E Stanley; C Cheers; K J Fowler; S Basu; Y F Zhan; A R Dunn
Journal:  Blood       Date:  1994-09-15       Impact factor: 22.113

10.  Mechanistic insights into caspase-9 activation by the structure of the apoptosome holoenzyme.

Authors:  Yini Li; Mengying Zhou; Qi Hu; Xiao-Chen Bai; Weiyun Huang; Sjors H W Scheres; Yigong Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-31       Impact factor: 11.205

View more
  18 in total

1.  Harnessing the Plasma Proteome to Mirror Current and Predict Future Cardiac Remodeling After Myocardial Infarction.

Authors:  Upendra Chalise; Mediha Becirovic-Agic; Jocelyn R Rodriguez-Paar; Shelby R Konfrst; Sharon D B de Morais; Catherine S Johnson; Elizabeth R Flynn; Michael E Hall; Daniel R Anderson; Leah M Cook; Kristine Y DeLeon-Pennell; Merry L Lindsey
Journal:  J Cardiovasc Transl Res       Date:  2022-10-05       Impact factor: 3.216

2.  Neutrophil crosstalk during cardiac wound healing after myocardial infarction.

Authors:  Upendra Chalise; Mediha Becirovic-Agic; Merry L Lindsey
Journal:  Curr Opin Physiol       Date:  2022-01-31

Review 3.  Fibrotic Signaling in Cardiac Fibroblasts and Vascular Smooth Muscle Cells: The Dual Roles of Fibrosis in HFpEF and CAD.

Authors:  Julian C Bachmann; Simon J Baumgart; Anna K Uryga; Markus H Bosteen; Giulia Borghetti; Michael Nyberg; Kate M Herum
Journal:  Cells       Date:  2022-05-17       Impact factor: 7.666

Review 4.  Modulation of mTOR Signaling in Cardiovascular Disease to Target Acute and Chronic Inflammation.

Authors:  Madlen Kaldirim; Alexander Lang; Susanne Pfeiler; Pia Fiegenbaum; Malte Kelm; Florian Bönner; Norbert Gerdes
Journal:  Front Cardiovasc Med       Date:  2022-06-29

5.  S100A9 is a functional effector of infarct wall thinning after myocardial infarction.

Authors:  Upendra Chalise; Mediha Becirovic-Agic; Michael J Daseke; Shelby R Konfrst; Jocelyn R Rodriguez-Paar; Dan Feng; Jeffrey D Salomon; Daniel R Anderson; Leah M Cook; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-12-10       Impact factor: 5.125

6.  Reperfused vs. nonreperfused myocardial infarction: when to use which model.

Authors:  Merry L Lindsey; Lisandra E de Castro Brás; Kristine Y DeLeon-Pennell; Nikolaos G Frangogiannis; Ganesh V Halade; Caitlin C O'Meara; Francis G Spinale; Zamaneh Kassiri; Jonathan A Kirk; Petra Kleinbongard; Crystal M Ripplinger; Keith R Brunt
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-06-11       Impact factor: 5.125

7.  Cardiac fibrosis: Pathobiology and therapeutic targets.

Authors:  Michael P Czubryt; Taben M Hale
Journal:  Cell Signal       Date:  2021-06-17       Impact factor: 4.850

Review 8.  Immune Cells and Immunotherapy for Cardiac Injury and Repair.

Authors:  Joel G Rurik; Haig Aghajanian; Jonathan A Epstein
Journal:  Circ Res       Date:  2021-05-27       Impact factor: 23.213

Review 9.  Infarct in the Heart: What's MMP-9 Got to Do with It?

Authors:  Mediha Becirovic-Agic; Upendra Chalise; Michael J Daseke; Shelby Konfrst; Jeffrey D Salomon; Paras K Mishra; Merry L Lindsey
Journal:  Biomolecules       Date:  2021-03-25

Review 10.  HMGB1-Mediated Activation of the Inflammatory-Reparative Response Following Myocardial Infarction.

Authors:  Eleonora Foglio; Laura Pellegrini; Matteo Antonio Russo; Federica Limana
Journal:  Cells       Date:  2022-01-10       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.